BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12849825)

  • 1. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding.
    Abbott J; Hawe J; Hunter D; Garry R
    Fertil Steril; 2003 Jul; 80(1):203-8. PubMed ID: 12849825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
    Hawe J; Abbott J; Hunter D; Phillips G; Garry R
    BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cavaterm thermal balloon endometrial ablation versus hysteroscopic endometrial resection to treat menorrhagia: the French, multicenter, randomized study.
    Brun JL; Raynal J; Burlet G; Galand B; Quéreux C; Bernard P
    J Minim Invasive Gynecol; 2006; 13(5):424-30. PubMed ID: 16962526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NovaSure impedance-controlled system for endometrial ablation.
    Gallinat A; Nugent W
    J Am Assoc Gynecol Laparosc; 2002 Aug; 9(3):283-9. PubMed ID: 12101323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial.
    Athanatos D; Pados G; Venetis CA; Stamatopoulos P; Rousso D; Tsolakidis D; Stamatopoulos CP; Tarlatzis BC
    Clin Exp Obstet Gynecol; 2015; 42(3):347-51. PubMed ID: 26152008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia.
    Cooper J; Gimpelson R; Laberge P; Galen D; Garza-Leal JG; Scott J; Leyland N; Martyn P; Liu J
    J Am Assoc Gynecol Laparosc; 2002 Nov; 9(4):418-28. PubMed ID: 12386350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life should be considered the primary outcome for measuring success of endometrial ablation.
    Abbott JA; Hawe J; Garry R
    J Am Assoc Gynecol Laparosc; 2003 Nov; 10(4):491-5; discussion 495. PubMed ID: 14738636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation.
    Kleijn JH; Engels R; Bourdrez P; Mol BW; Bongers MY
    BJOG; 2008 Jan; 115(2):193-8. PubMed ID: 17617188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial ablation with NovaSure GEA, a pilot study.
    Busund B; Erno LE; Grønmark A; Istre O
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):65-8. PubMed ID: 12580843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and comparison of intraoperative and postoperative pain associated with NovaSure and ThermaChoice endometrial ablation systems.
    Laberge PY; Sabbah R; Fortin C; Gallinat A
    J Am Assoc Gynecol Laparosc; 2003 May; 10(2):223-32. PubMed ID: 12732777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial ablation with the NovaSure system in Iran.
    Asgari Z; Moini A; Samiee H; Tehranian A; Mozafar-Jalali S; Sabet S
    Int J Gynaecol Obstet; 2011 Jul; 114(1):73-5. PubMed ID: 21507403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial ablation with the Cavaterm thermal balloon.
    Alaily AB; Auld BJ; Diab Y
    J Obstet Gynaecol; 2003 Jan; 23(1):51-4. PubMed ID: 12623485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial ablation with paracervical block.
    Penninx JP; Mol BW; Bongers MY
    J Reprod Med; 2009 Oct; 54(10):617-20. PubMed ID: 20677480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal balloon endometrial ablation in the treatment of heavy menstrual bleeding.
    Bouzari Z; Yazdani S; Azimi S; Delavar MA
    Med Arch; 2014 Dec; 68(6):411-3. PubMed ID: 25648851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients.
    Gallinat A
    Am J Obstet Gynecol; 2004 Nov; 191(5):1585-9. PubMed ID: 15547528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prospective, Multicenter, Pivotal Trial to Evaluate the Safety and Effectiveness of the AEGEA Vapor Endometrial Ablation System.
    Levie MD; Chudnoff SG
    J Minim Invasive Gynecol; 2019; 26(4):679-687. PubMed ID: 30036631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NovaSure bipolar radiofrequency endometrial ablation: report of 200 cases.
    Baskett TF; Clough H; Scott TA
    J Obstet Gynaecol Can; 2005 May; 27(5):473-6. PubMed ID: 16100642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysteroscopic endometrial ablation without endometrial preparation.
    Yin CS; Wei RY; Chao TC; Chan CC
    Int J Gynaecol Obstet; 1998 Aug; 62(2):167-72. PubMed ID: 9749888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial resection / ablation techniques for heavy menstrual bleeding.
    Lethaby A; Hickey M; Garry R; Penninx J
    Cochrane Database Syst Rev; 2009 Oct; (4):CD001501. PubMed ID: 19821278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of HydroThermAblator and rollerball endometrial ablation for menorrhagia 3 Years after treatment.
    Goldrath MH
    J Am Assoc Gynecol Laparosc; 2003 Nov; 10(4):505-11. PubMed ID: 14738639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.